Newron Pharmaceuticals SpA (NWPHF) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Newron Pharmaceuticals SpA (NWPHF) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Newron Pharmaceuticals SpA

· NWPHF

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

207.954 M

+0.00%

General

Market Cap: $207.95M
Enterprise Value: $197.02M
Shares Outstanding: 20,810,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 100.03%
Operating Margin: -216.76%
Net Profit Margin: -283.10%
FCF Margin: -115.95%
ROA: -72.94%
ROE: 258.11%
ROIC: -80.64%
Current Ratio: 3.15
Debt-to-Equity: -3.34
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -8.80

Growth

Rev 1Y: -62.78%
Rev 1Y Fwd Est: -27.74%
Rev 3Y (CAGR): 46.41%
Rev 5Y (CAGR): 29.47%
Rev 10Y (CAGR): 23.17%
EPS 1Y: -178.82%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $11.7M
Gross Margin: 100.03%
Operating Expenses: $36.85M
Operating Income: -$25.35M
Net Profit: -$33.11M

Balance Sheet

Cash and Equivalents: $18.13M
Working Capital: $30.37M
Total Assets: $45.39M
Net Debt: $25.85M
Total Liabilities: $58.55M
Total Equity: -$13.16M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$13.52M
Cash Flow from Investing: -$138.5K
Cash Flow from Financing: $1.55M
Free Cash Flow: -$13.56M
Capital Expenditures: $41.14K